Hair Loss Treatment Manufacturing in the US - Industry Market Research Report

Hair Loss Treatment Manufacturing in the US - Industry Market Research Report

Hair Loss Treatment Manufacturing in the US

The proliferation of low-cost generic oral hair loss treatments in recent years has made such treatments more accessible. However, the prevalence of generic products has intensified competitive price pressures, adversely affecting industry revenue. Furthermore, demand for hair loss treatments declined in 2020 because of COVID-19. Also, consumer confidence has dropped for most of the period and soaring inflation has caused interest rates to skyrocket. So, industry-wide revenue has been decreasing at a CAGR of 2.0% over the past five years, including an estimated 3.3% increase in the current year, and is expected to total $3.8 billion in 2023. In the same year, profit is projected to plateau to 9.6%.

This industry develops and produces solutions that prevent or restore hair loss. Products in this industry include topical applications, orally ingestible treatments, hair transplants and laser follicle stimulation.

This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.